POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ — POMDOCTOR LIMITED ("Pomdoctor" or the…CISION PRNewswireOctober 19, 2026
Press ReleaseBinance Launches Binance AI Pro, Bringing Conversational AI Strategy Building to Users The finance-focused AI agent turns plain-language trading ideas into tested, automated strategies,…CISION PRNewswireOctober 19, 2026
Press ReleaseHyosung Chairman Hyun-Joon Cho Advances Bio-Based Materials Strategy with Commercial Bio-BDO Production in Vietnam Chairman Cho positions bio-based materials as a core pillar of Hyosung’s long-term…CISION PRNewswireOctober 19, 2026
Transcenta Therapeutics Announces Appointment of Ms. Jennie Ma as Chief Financial Officer SUZHOU, China and PRINCETON, N.J., Oct. 19, 2026 /PRNewswire/ — Transcenta Therapeutics…CISION PRNewswireOctober 19, 2026
Akeso Announces Opening of Global Phase II Study of Ivonescimab in First-Line Clear Cell Renal Cell Carcinoma, Including Combination with Cadonilimab HONG KONG, Oct. 19, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or…CISION PRNewswireOctober 19, 2026
OncoC4 Announces NMPA Acceptance of Two IND Applications for Cesalatamig Combination Studies with ADCs and Pan-RAS Inhibitors — New Studies Expand Cesalatamig into Biomarker-driven Precision Immuno-oncology Strategies — Cesalatamig is Also…CISION PRNewswireOctober 19, 2026
Press ReleaseJulia Gillard joins Hakluyt's International Advisory Board LONDON, Oct. 19, 2026 /PRNewswire/ — Hakluyt, the global strategic advisory firm…CISION PRNewswireOctober 19, 2026
Press Release2026 Canton Fair Design Award Winners Showcase China's Innovation Strength GUANGZHOU, China, Oct. 19, 2026 /PRNewswire/ — As the 140th Canton Fair…CISION PRNewswireOctober 19, 2026